Exponent (FRA:EP5) Common Stock : €0.1 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Exponent Common Stock?

Exponent's quarterly common stock declined from Sep. 2023 (€0.1 Mil) to Dec. 2023 (€0.1 Mil) but then stayed the same from Dec. 2023 (€0.1 Mil) to Mar. 2024 (€0.1 Mil).

Exponent's annual common stock increased from Dec. 2021 (€0.1 Mil) to Dec. 2022 (€0.1 Mil) but then declined from Dec. 2022 (€0.1 Mil) to Dec. 2023 (€0.1 Mil).

Exponent Common Stock Historical Data

The historical data trend for Exponent's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exponent Common Stock Chart

Exponent Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.06

0.05

0.06

Exponent Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															0.06	0.06	0.06	0.06	0.06

Exponent Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Exponent (FRA:EP5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Exponent Inc (FRA:EP5) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

EXPO:USA

Address

149 Commonwealth Drive, Menlo Park, CA, USA, 94025

Website

https://www.exponent.com

Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

Exponent (FRA:EP5) Headlines

No Headlines